UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Major histocompatibility complex class I-associated vaccine protection from Simian immunodeficiency virus-infected peripheral blood cells

The Journal of experimental medicine, 1994-08, Vol.180 (2), p.769-774

1994

Link zum Volltext

Verfügbarkeit prüfen

Induction of anti-simian immunodeficiency virus cellular and humoral immune responses in rhesus macaques by peptide immunogens: correlation of CTL activity and reduction of cell-associated but not plasma virus load following challenge

Journal of general virology, 2002-01, Vol.83 (1), p.81-91

2002

Link zum Volltext

Verfügbarkeit prüfen

Decline of Simian Immunodeficiency Virus (SIV)-Specific Cytotoxic T Lymphocytes in the Peripheral Blood of Long-Term Nonprogressing Macaques Infected with SIVmac32H-J5

The Journal of infectious diseases, 1999-10, Vol.180 (4), p.1133-1141

1999

Link zum Volltext

Verfügbarkeit prüfen

Rapid screening for Mamu-A1-positive rhesus macaques using a SIVmac Gag peptide-specific cytotoxic T-lymphocyte assay

Immunology, 1995-03, Vol.84 (3), p.482-487

1995

Link zum Volltext

Verfügbarkeit prüfen

Control of initial viraemia coincides with neutralizing antibody response after SIVmac infection of rhesus macaques

AIDS (London), 1996-06, Vol.10 (6), p.681-682

1996

Link zum Volltext

Verfügbarkeit prüfen

Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus

Virology (New York, N.Y.), 2006-07, Vol.351 (1), p.133-144

2006

Link zum Volltext

Verfügbarkeit prüfen

Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model

Vaccine, 2006-03, Vol.24 (11), p.1811-1820

2006

Link zum Volltext

Verfügbarkeit prüfen

Antigenicity and immunogenicity of recombinant envelope glycoproteins of SIVmac32H with different in vivo passage histories

Vaccine, 1995, Vol.13 (13), p.1187-1197

1995

Link zum Volltext

Verfügbarkeit prüfen

Vaccine protection from CD4+ T-cell loss caused by simian immunodeficiency virus (SIV) mac251 is afforded by sequential immunization with three unrelated vaccine vectors encoding multiple SIV antigens

Journal of general virology, 2004-10, Vol.85 (10), p.2915-2924

2004

Link zum Volltext

Verfügbarkeit prüfen

Vaccine protection and reduced virus load from heterologous macaque-propagated SIV challenge

AIDS research and human retroviruses, 1994, Vol.10, p.S117-S121

1994

Link zum Volltext

Verfügbarkeit prüfen

Protection from Pathogenic SIVmac Challenge Following Short-Term Infection with a Nef-Deficient Attenuated Virus

Virology (New York, N.Y.), 1996-05, Vol.219 (1), p.195-205

1996

Link zum Volltext

Verfügbarkeit prüfen

Vaccine protection from CD4 super(+) T-cell loss caused by simian immunodeficiency virus (SIV) mac251 is afforded by sequential immunization with three unrelated vaccine vectors encoding multiple SIV antigens

Journal of general virology, 2004-10, Vol.85 (10), p.2915-2924

2004

Link zum Volltext

Verfügbarkeit prüfen

Sustained Conservation of CD4 super(+) T Cells in Multiprotein Triple Modality-Immunized Rhesus Macaques after Intrarectal Challenge with Simian Immunodeficiency Virus

Viral Immunology, 2006-01, Vol.19 (3), p.448-457

2006

Link zum Volltext

Verfügbarkeit prüfen

Analysis of SIV-specific CTL in the rhesus macaque model of AIDS: the use of simian fibroblasts as an alternative source of target cells for chromium release assays

Journal of immunological methods, 2001-12, Vol.258 (1), p.137-140

2001

Link zum Volltext

Verfügbarkeit prüfen

In vivo resistance to simian immunodeficiency virus superinfection depends on attenuated virus dose

Journal of general virology, 1998-08, Vol.79 (8), p.1935-1944

1998

Link zum Volltext

Verfügbarkeit prüfen

Vaccine Development Using the Simian Immunodeficiency Virus Model for AIDS

Intervirology, 2002, Vol.45 (4-6), p.267-274

2002

Link zum Volltext

Verfügbarkeit prüfen

Induction of antibodies against SIV antigens after intramuscular nucleic acid inoculation using complex expression constructs

Journal of biotechnology, 1996-01, Vol.44 (1), p.59-65

1996

Link zum Volltext

Verfügbarkeit prüfen

Vaccine protection against SIVmac infection by high- but not low-dose whole inactivated virus immunogen

Journal of acquired immune deficiency syndromes (1988), 1992, Vol.5 (5), p.461-468

1992

Link zum Volltext

Verfügbarkeit prüfen

SIVMAC vaccine studies using whole inactivated virus antigen sequentially depleted of viral proteins

Journal of medical primatology, 1998-08, Vol.27 (4), p.184-192

1998

Link zum Volltext

Verfügbarkeit prüfen

Vaccine protection and reduced virus load from heterologous macaque-propagated SIV challenge

AIDS research and human retroviruses, 1994-01, Vol.10, p.no. 2 sul.-no. 2 sul.

1994

Link zum Volltext

Verfügbarkeit prüfen

A novel small animal model to study the replication of simian foamy virus in vivo

Virology (New York, N.Y.), 2014-01, Vol.448, p.65-73

2014

Link zum Volltext

Verfügbarkeit prüfen

Atraumatic Oral Spray Immunization with Replication-Deficient Viral Vector Vaccines

Journal of Virology, 2007-12, Vol.81 (23), p.13180-13190

2007

Link zum Volltext

Verfügbarkeit prüfen

Suppressing active replication of a live attenuated simian immunodeficiency virus vaccine does not abrogate protection from challenge

Virology (New York, N.Y.), 2016-02, Vol.489, p.1-11

2016

Link zum Volltext

Verfügbarkeit prüfen

Role of complement and antibodies in controlling infection with pathogenic simian immunodeficiency virus (SIV) in macaques vaccinated with replication-deficient viral vectors

Retrovirology, 2009-06, Vol.6 (1), p.60-60, Article 60

2009

Link zum Volltext

Verfügbarkeit prüfen

SIVagm containing the SHIV89.6P Envelope gene replicates poorly and is non-pathogenic

Virology (New York, N.Y.), 2010-03, Vol.399 (1), p.87-97

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

ThemaMacaca Mulatta

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)
Japanisch
(1)

Erscheinungsjahr

n.n

Zeitschrift / Serie

Virology
(5)
Journal Of General Virology
(4)
Aids Research And Human Retroviruses
(2)
Journal Of Biotechnology
(2)
Vaccine
(2)
Viral Immunology
(2)
Aids
(1)
Immunology
(1)
Intervirology
(1)
Journal Of Acquired Immune Deficiency Syndromes
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Major histocompatibility complex class I-associated vaccine protection from Simian immunodeficiency virus-infected peripheral blood cells

Induction of anti-simian immunodeficiency virus cellular and humoral immune responses in rhesus macaques by peptide immunogens: correlation of CTL activity and reduction of cell-associated but not plasma virus load following challenge

Decline of Simian Immunodeficiency Virus (SIV)-Specific Cytotoxic T Lymphocytes in the Peripheral Blood of Long-Term Nonprogressing Macaques Infected with SIVmac32H-J5

Rapid screening for Mamu-A1-positive rhesus macaques using a SIVmac Gag peptide-specific cytotoxic T-lymphocyte assay

Control of initial viraemia coincides with neutralizing antibody response after SIVmac infection of rhesus macaques

Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus

Reduction of viral loads by multigenic DNA priming and adenovirus boosting in the SIVmac-macaque model

Antigenicity and immunogenicity of recombinant envelope glycoproteins of SIVmac32H with different in vivo passage histories

Vaccine protection from CD4+ T-cell loss caused by simian immunodeficiency virus (SIV) mac251 is afforded by sequential immunization with three unrelated vaccine vectors encoding multiple SIV antigens

Vaccine protection and reduced virus load from heterologous macaque-propagated SIV challenge

Protection from Pathogenic SIVmac Challenge Following Short-Term Infection with a Nef-Deficient Attenuated Virus

Vaccine protection from CD4 super(+) T-cell loss caused by simian immunodeficiency virus (SIV) mac251 is afforded by sequential immunization with three unrelated vaccine vectors encoding multiple SIV antigens

Sustained Conservation of CD4 super(+) T Cells in Multiprotein Triple Modality-Immunized Rhesus Macaques after Intrarectal Challenge with Simian Immunodeficiency Virus

Analysis of SIV-specific CTL in the rhesus macaque model of AIDS: the use of simian fibroblasts as an alternative source of target cells for chromium release assays

In vivo resistance to simian immunodeficiency virus superinfection depends on attenuated virus dose

Vaccine Development Using the Simian Immunodeficiency Virus Model for AIDS

Induction of antibodies against SIV antigens after intramuscular nucleic acid inoculation using complex expression constructs

Vaccine protection against SIVmac infection by high- but not low-dose whole inactivated virus immunogen

SIVMAC vaccine studies using whole inactivated virus antigen sequentially depleted of viral proteins

Vaccine protection and reduced virus load from heterologous macaque-propagated SIV challenge

A novel small animal model to study the replication of simian foamy virus in vivo

Atraumatic Oral Spray Immunization with Replication-Deficient Viral Vector Vaccines

Suppressing active replication of a live attenuated simian immunodeficiency virus vaccine does not abrogate protection from challenge

Role of complement and antibodies in controlling infection with pathogenic simian immunodeficiency virus (SIV) in macaques vaccinated with replication-deficient viral vectors

SIVagm containing the SHIV89.6P Envelope gene replicates poorly and is non-pathogenic

Aktive Filter

Suchergebnisse filtern